This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 May;18(9):2004-6.

doi: 10.1200/JCO.2000.18.9.2004.

Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: a critique

PMID: 10784645
DOI: 10.1200/JCO.2000.18.9.2004

Comment

Dexrazoxane and the ASCO guidelines for the use of chemotherapy and radiotherapy protectants: a critique

K Hellmann. J Clin Oncol. 2000 May.

. 2000 May;18(9):2004-6.

doi: 10.1200/JCO.2000.18.9.2004.

Author

PMID: 10784645
DOI: 10.1200/JCO.2000.18.9.2004

No abstract available

PubMed Disclaimer

Comment in

Dexrazoxane in anthracycline extravasation.
Langer SW, Sehested M, Jensen PB, Buter J, Giaccone G. Langer SW, et al. J Clin Oncol. 2000 Aug;18(16):3064. J Clin Oncol. 2000. PMID: 10944144 No abstract available.

Comment on

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.
Swain SM, Whaley FS, Gerber MC, Weisberg S, York M, Spicer D, Jones SE, Wadler S, Desai A, Vogel C, Speyer J, Mittelman A, Reddy S, Pendergrass K, Velez-Garcia E, Ewer MS, Bianchine JR, Gams RA. Swain SM, et al. J Clin Oncol. 1997 Apr;15(4):1318-32. doi: 10.1200/JCO.1997.15.4.1318. J Clin Oncol. 1997. PMID: 9193323 Clinical Trial.
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.
Swain SM, Whaley FS, Gerber MC, Ewer MS, Bianchine JR, Gams RA. Swain SM, et al. J Clin Oncol. 1997 Apr;15(4):1333-40. doi: 10.1200/JCO.1997.15.4.1333. J Clin Oncol. 1997. PMID: 9193324 Clinical Trial.
American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, Gradishar WJ, Green DM, Langdon RJ Jr, Mitchell RB, Negrin R, Szatrowski TP, Thigpen JT, Von Hoff D, Wasserman TH, Winer EP, Pfister DG. Hensley ML, et al. J Clin Oncol. 1999 Oct;17(10):3333-55. doi: 10.1200/JCO.1999.17.10.3333. J Clin Oncol. 1999. PMID: 10506637

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information